New Study to Get More Minorities Involved in Genetic Testing
978 articles
Fighting On To See Her Children Grow Up
Despite aggressive pancreatic cancer, with a BRCA-like genetic mutation, Dr. Jill Pechacek is determined to stay alive to see her children grow up.
New Pain Control Technology for Locally Advanced Pancreatic Cancer
Dr. Hani Babiker outlines the results of the PANOVA-3 trial, which tested Tumor Treating Fields and chemotherapy for pain control.
A New Combination Chemotherapy Before Surgery
A new clinical trial adds vitamin D to standard of care chemotherapy before surgery, to make pancreatic cancer tumors more removable.
Reading the Scientific Study to Understand a Pancreatic Cancer Treatment
How can you tell if a scientific study is good? Learn what to look for in reliable studies and whether there may be a trial to pursue.
Patients Needed for Clinical Trial/Research Study of Treatment Targeting Immune System
A clinical trial seeks pancreatic cancer patients with the MSI (microsatellite instability) genetic signature, to test an immunotherapy drug.
New Vaccine Harnesses Power Of the Lymph Nodes
A promising new vaccine targets KRAS, the most common mutation in pancreatic cancer. Dr. Shubham Pant provides an update.
A New Approach to Overcome Drug Resistance
Dr. Despina Siolas is leading one of the sites where a new drug combination to combat the effects of KRAS mutations is under trial.
New Study Tackles the Link Between Sleep Disruption and Cachexia
Cachexia occurs frequently among pancreatic cancer patients. Dr. Evan Noch is looking at how sleep disruption and cachexia interact.
The Relatively New Procedure of Irreversible Electroporation Has Given Me Time
When chemotherapy and radiation stopped working, Leslie Wineberg was glad to qualify for irreversible electroporation (IRE).
Pancreatic Cancer Leads to a New Direction
After Sheila Sky Kasselman recovered from pancreatic cancer treatment, she became a pancreatic cancer activist, determined to help find more treatments.
A New Sidekick in Your Pancreatic Cancer Journey: Artificial Intelligence
Pancreatic neuroendocrine tumor patient Burt Rosen uses artificial intelligence to help him understand medical data, and to make him laugh.
Testing Standard Treatment Plus an Antibody to Shrink Pancreatic Tumors
Researchers are testing whether adding a monoclonal antibody to standard chemotherapy will make locally advanced pancreatic cancer qualify for surgery.
Let’s Win and the Elvin Howard, Sr. PCAF Raise Awareness with a New PSA
The Elvin Howard, Sr. Pancreatic Cancer Advocacy Foundation and Let’s Win release a new PSA to raise awareness of pancreatic cancer in people of color.
New Pancreatic Cancer Public Service Announcement
Let’s Win and the Elvin Howard Sr. Pancreatic Cancer Advocacy Foundation announce a joint public service announcement in a press release.
Let’s Win! Pancreatic Cancer Foundation Appoints Two New Board Members
David Glauber and Sergeant Elvin Howard, Jr., have been appointed to the Let’s Win Board of Directors, effective July 2020.